Compugen Ltd. to Present at Drug Discovery Chemistry 2007

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ:CGEN) announced today that it will present its G-protein coupled receptor (GPCR) discovery engine and its eight recently discovered novel GPCR peptide ligands at the upcoming Drug Discovery Chemistry 2007 conference at 4:15 PM (Pacific Time) on Tuesday, May 15, 2007 at the Hilton La Jolla Torrey Pines hotel in La Jolla, California.

MORE ON THIS TOPIC